We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current ACET market cap is 72.52M. The company's latest EPS is USD -3.3050 and P/E is -0.69.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -22.99M | -31.57M | -33.32M | -34.89M | -52.26M |
| Net Income | -22M | -29.88M | -30.88M | -32.4M | -49.89M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 17.9M | 9.73M | 24.99M | 0 |
| Operating Income | -85.46M | -39.19M | -62.04M | -72.55M | -152.04M |
| Net Income | -82.74M | -36.68M | -62M | -69.79M | -142.66M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 354.3M | 330.69M | 304.97M | 277.63M | 233.26M |
| Total Liabilities | 36.65M | 38.35M | 38.76M | 38.57M | 38.58M |
| Total Equity | 317.66M | 292.34M | 266.22M | 239.06M | 194.68M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 93.91M | 153.84M | 338.94M | 330.69M | 207.3M |
| Total Liabilities | 12.21M | 44.01M | 35.81M | 38.35M | 37.12M |
| Total Equity | 81.7M | 109.83M | 303.13M | 292.34M | 170.18M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -25.93M | -44.77M | -24.09M | -48.99M | -70.23M |
| Investing | -10.29M | -16.78M | -1.92M | -3.42M | -4.33M |
| Financing | 41.21M | 41.51M | -7k | 219k | 160k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -73.68M | -43.85M | -51.05M | -44.77M | -93.72M |
| Investing | 44.13M | 115.22M | -2.8M | -16.78M | -4.46M |
| Financing | 56.45M | 303k | 242.69M | 41.51M | 236k |
| Market Cap | 72.52M |
| Price to Earnings Ratio | -0.69 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.62 |
| Price to Book Ratio | 0.58 |
| Dividend Yield | - |
| Shares Outstanding | 43.16M |
| Average Volume (1 week) | 895.19k |
| Average Volume (1 Month) | 682.13k |
| 52 Week Change | -72.32% |
| 52 Week High | 7.50 |
| 52 Week Low | 1.10 |
| Spread (Intraday) | 0.04 (2.33%) |
| Company Name | Adicet Bio Inc |
| Address |
corporation trust center 1209 orange st wilmington, delaware 19801 |
| Website | https://www.adicetbio.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
